
Attitude to eye health criticised
Market research by the New Zealand arm of Roche, a Swiss multinational holding healthcare company, was released last week and said while most people understood the importance of vision, public awareness of specific eye conditions, symptoms and how to prevent vision loss remained low.
"New Zealanders overwhelmingly value their vision above all other senses according to recent market research, with participants saying they'd be willing to lose 5.6 years of perfect health, rather than live a decade without sight," the company's media release began.
In New Zealand, Roche distributes Vabysmo, a medicine approved by MedSafe to treat age-related macular degeneration, the leading cause of blindness in the country.
Blind and low vision advocate and Dunedin resident Julie Woods, who is also known as "That Blind Woman", said it "distresses" her the company was comparing hypothetical trade-offs between life expectancy and vision loss.
"That just shows how afraid people are of vision loss," she said.
"You can live a perfectly good life without vision, but you can't without your health."
She said preserving eye health was "obviously" a great cause.
"But it doesn't give organisations the right to push their own product and put down [or punch] down a community of people."
Ms Woods said Roche's approach spoke to a medical model of disability which was: "we can't fix you, therefore you're broken".
"Whereas the social model of disability says that we are disabled by the barriers that society creates, and we're not broken and we're not less than."
She said Roche's use of New Zealanders' fears of not seeing loved ones' faces or recognising facial expressions, body language and social cues was "bull...." and was emotive toward sighted people.
A Roche spokesperson said the market research was based on a similar study conducted in the United Kingdom and the company sought guidance from professionals within the eye community, including a patient advocacy group.
"Their advice advocated for raising awareness about the importance of eye health and regular eye examinations to prevent irreversible, yet preventable, vision loss," the spokesperson said.
"The intent of the campaign was to raise awareness of the importance of eye health and preventable vision loss, encouraging individuals to get their eyes tested or seek help if they are experiencing symptoms."
The spokesperson said Roche respected Ms Woods' opinion and acknowledged her advocacy for the blind and low vision community in New Zealand.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


NZ Herald
2 hours ago
- NZ Herald
What's it like living with sarcoidosis
Sarcoidosis usually affects the lungs, although it can affect every system in the body. Photo / Getty Images Online only What's It Like To Be is a regular column where New Zealanders from all walks of life share first-hand experiences of living with and overcoming health challenges. Here, Donna Thomas, 58, tells Paulette Crowley about living with sarcoidosis, a rare inflammatory and autoimmune condition. I was planting some trees in my garden one day and put some compost down. I didn't put a mask on while I was doing this, which was really silly. I remember leaning over the compost bag and noticing the tiniest puff of dust going up my nostril. That was in December 2021. After that, I had some trouble breathing – shortness of breath – and didn't feel well. I went to the doctor's a few times, maybe. Then in April, I had some chest pain. My daughter drove me down to the hospital, where I ended up having a CT scan. That's when they saw a granuloma – kind of a lump of infection – on my lung. They had to remove the upper right lobe of my lung to biopsy it. That procedure didn't go smoothly, as my ribs dislocated during the surgery. It's called a subluxation and the surgeon was kind of blown away because it's unusual. But when I look back from where I've landed now, I must have been in a highly inflamed state. I was finally diagnosed with sarcoidosis, an autoinflammatory disease, in March 2022 by a respiratory physician. I learnt that well over 90% of sarcoidosis cases start in the lungs, but can go on to affect different parts of the body. About 5% of people will end up with it affecting their neurology – it's called neurosarcoidosis. That's what I have ended up with. Donna Thomas (left) before she was diagnosed with sarcoidosis. She now has regular medical appointments, and struggles with a range of health issues. Photo / Supplied Sarcoidosis is definitely one of the rarest rare disorders. The specialist who diagnosed me said most GPs would never see a case in their medical lifetimes. They call it a snowflake disease because everyone who has sarcoidosis presents so differently, meaning that much like snowflakes, no two cases are alike. This is a really big challenge for medical people, and for me as well. I had a consult with a new neurologist recently. When I asked him if he knew about sarcoidosis, he just didn't say anything. We look to medical professionals to treat us and if they don't know what's going on, it's really scary. Some of the ways that sarcoidosis affects me is that my legs, hands and feet ache. This can wake me at night. I also get cramping and burning in my muscles and I've got numbness and tingling in my fingers and toes. My cognition is also affected – I find it hard to remember things – and I get very fatigued. Sarcoidosis accelerates many conditions. I've had significant surgery around my mouth to get basal cells removed and I have cataracts that are coming on hard and fast. I've also just found out I need a hip replacement. I now live a different life to what I used to. I was a trauma specialist and managed a team of 70 people before I was medically retired. I was working 60 hours a week, like lots of people do. Back then, I could spin a lot of plates, you know, just throw anything at me and I'd just shuffle it around. And it always makes me want to cry because I miss my career, but I can't do that anymore. Now, it's not about trying to be who I was but trying to function in a way that I'm not lying in bed all day. Obviously, I can't work, but I might get in two productive hours a day, doing housework and tidying up. I have to take things slowly. If I've got medical appointments, the next day has to be a rest day because my brain and body are just tired. There's a massive spectrum with sarcoidosis – depending on the type of disease, some people can be fine, and lots will go into remission. I don't know if I'd say my disease is at the top of the chain, because I have refractory sarcoidosis, which is chronic and progressive. Frontline treatments haven't worked to put me into remission. Now, we're at the next level of treatment and the last thing we've got to try, at the moment, is a medication called infliximab. The hope is that it will bottom out my immunity and my inflammation levels will drop. I am so, so far away from the person I used to be and have a lot of grief still around that. But you know, you've just got to kind of get on with things. I can either lay down and die or stand up and live the best life I can with this. Grief just takes away time from family and it's made me realise that work's not the most important thing in the world. I've got five kids and my ninth grandchild on the way, so now, it's more family time for me. And more and more I just want to do the things I enjoy, not the things I have to do. Sarcoidosis usually affects people's lungs, although it can affect every system in the body. It mainly occurs in people, especially women, between 25 and 45 years of age. Some studies have suggested there might be a link between sarcoidosis and environmental factors, including potting mix. Some people will have no symptoms from sarcoidosis or have mild, treatable symptoms that clear within a few years. For others, symptoms can become widespread, chronic and hard to treat. To donate to Donna's givealittle, go to


Scoop
14 hours ago
- Scoop
Orewa Local Gets #GutsyForGutCancer Running 161km In Under 24 Hours
Orewa local Neville Modlin inspired his community this past weekend running 161.8km in 23 hours and 55 minutes to pay tribute to his father who recently passed away from pancreatic cancer. In late November 2024 when Neville Modlin's father casually mentioned he was feeling 'a little under the weather' their family had no idea that his funeral would be held on New Years Eve that same year. Neville's father passed away only 6 weeks later after a short and intense journey with pancreatic cancer which is becoming one of New Zealand's deadliest cancers with 88% of Kiwis passing away within 5 years of diagnosis. Neville says 'the speed that everything progressed for my dad was totally unexpected.' Within 10 days they were planning the estate, after 15 he became an expert in cancer medication and in 30 he was organising fulltime care and planning a funeral. Not to mention supporting his mum throughout the process who was navigating losing her life partner of over 60 years. Neville channelled his grief into action, taking on his biggest personal challenge in part of The Gut Cancer Foundation's #GutsyForGutCancer raising critical funds and awareness for Kiwis battling gut cancer. 'What began as a personal challenge became a public journey. I never expected the magnitude of what unfolded, besides the first 4km I was never alone' Neville says. Even at 3am he had local runners coming out to show their support and run alongside him, some whom he had never met before. Neville and his family have been blown away by the communities support both on the day and in the fundraising campaign as they've now surpassed their initial fundraising goal by almost 6 times! Like many New Zealanders Neville didn't know much about gut cancers when his father was diagnosed, 'because he went downhill so fast there was little support – We were figuring it out one day at a time.' Liam Willis, Executive Officer of The Gut Cancer Foundation (GCF) highlights that gut cancer is the most common form of cancer in New Zealand with over 6,100 Kiwis diagnosed every year. 'They have some of the worst survival rates of any cancers;' 8 Kiwis die from gut cancer every day. The GCF funds innovative research, addresses barriers to treatment and is particularly focused on improving experiences similar to Neville's by establishing a comprehensive pipeline to support Kiwis with access to vital resources throughout the cancer journey for patients and whanau. Liam shares the GCF has created an online hub of resources that is a comprehensive source of information for anyone diagnosed with a gut cancer, adding 'our team are on hand to answer questions they or their whanau may have.' 'We are committed to developing this service to ensure we meet the need of our community and no one has to face a gut cancer diagnosis alone." The generosity of the GCF supporters and donations help gives New Zealanders access to international clinical trials and allows the foundation to continue to be the voice for our communities. 'By raising awareness of signs, symptoms and specific risk factors we hope to see these cancers detected earlier, increasing the chances of patients surviving their diagnosis.' says Liam.


Scoop
17 hours ago
- Scoop
Two In Five Kiwi Men Die Prematurely, New Movember Report Reveals
Press Release – Movember The report finds men are dying almost 4 years earlier than women, with heart disease, certain cancers and suicide leading the toll. Suicide is the number one cause of death for young men aged 1534, and three in every four New Zealanders who die by suicide are male. 12 August 2025 – Two in five men living in Aotearoa New Zealand die prematurely – before the age of 75 – most from causes we know how to prevent and treat. That's the stark reality revealed in The Real Face of Men's Health: Aotearoa New Zealand, a landmark new report from the Movember Institute of Men's Health. It's the most comprehensive look at men's health in New Zealand to date – and it makes the issue impossible to ignore. The report finds men are dying almost 4 years earlier than women, with heart disease, certain cancers and suicide leading the toll. Suicide is the number one cause of death for young men aged 15–34, and three in every four New Zealanders who die by suicide are male. Among young tāne Māori aged 25–44, the suicide rate soars to nearly 60 deaths per 100,000 – the highest of any group in the country. 'These aren't just statistics – they're sons, fathers, brothers, and mates. And their deaths send shockwaves through whānau, workplaces and communities,' says report contributor Dr Simon Bennett (Ngāti Whakaue, Patu Harakeke, Ngāti Waewae), Director of Clinical Psychology Training at Massey University and member of Movember's Global Indigenous Advisory Committee. 'Too often, men are falling through the cracks, missing out on the critical support they need, when and where they need it most – and it has gone on for too long.' The research exposes major barriers stopping men from getting care – from masculine stereotypes and the expectation to 'tough it out', to health systems that too often feel unwelcoming or dismissive. Six in ten men say their concerns aren't taken seriously by healthcare providers, while nearly two-thirds feel masculine stereotypes have negatively influenced their health. 'If we addressed just the top five preventable diseases in men, New Zealand could have saved $917 million in 2023 alone,' says Professor Simon Rice, Global Director of the Movember Institute of Men's Health. 'The solutions exist. Now is the time for national action.' Movember is calling on the New Zealand Government to develop a Men's Health Strategy – grounded in equity and partnership with Māori – to deliver coordinated action across policy, services and systems. Because when men live longer, healthier lives — everyone benefits. 'This is a critical opportunity to change the trajectory of men's health in Aotearoa,' says Professor Rice. 'Healthier men mean healthier families, stronger communities and a stronger country.' New Zealanders can read the full report, which details the premature mortality of Kiwi men, the economic cost of poor men's health, the impact whānau and caregivers, and what's proven to work – and join the conversation at About Movember Movember is the leading global charity changing the face of men's health. What began as a bristly idea in Australia in 2003 quickly grew into a global movement – one that has sparked millions of important conversations, raised over AUD $1.83 billion for men's health, funded more than 1,300 health projects, and helped break the silence surrounding men's health issues. From breakthrough prostate and testicular cancer research to bold investments in mental health and suicide prevention, Movember is transforming how health services reach and support men. The charity works to ensure more men recognise when they're struggling, more supporters know how to step in, and health systems are better equipped to respond to men in need. Movember champions inclusive, gender-responsive healthcare — improving health outcomes not just for men, but for the families and communities they're part of. Together, we can help men live healthier, longer lives.